Annexon Biosciences Lands $44,000,000 Series B Funding Round

  • Feed Type
  • Date
    6/23/2016
  • Company Name
    Annexon Biosciences
  • Mailing Address
    280 Utah Avenue South San Francisco, CA 94080 USA
  • Company Description
    Annexon is a California-based healthcare company engaged in the R&D of novel disease-modifying drugs for neurodegenerative disorders.
  • Website
    http://www.annexonbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $44,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    This significant investment in our robust and risk-balanced pipeline further validates Annexon’s novel and elegant scientific approach. Moreover, the funding enables us to enhance and accelerate our biomarker-rich clinical development program in support of new and much-needed therapies for patients with serious neurodegenerative disorders.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Correlation Ventures
  • Venture Investor
    Novartis Venture Fund
  • Venture Investor
    Clarus Ventures
  • Venture Investor
    Satter Investment Management

Trending on Xconomy